Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function.

Saskia P Hagenaars | Ratko Radaković | Christopher Crockford | Chloe Fawns-Ritchie | International FTD-Genomics Consortium (IFGC) | Sarah E Harris | Catharine R Gale | Ian J Deary
PloS one | 2018

Neurodegenerative disorders are associated with impaired cognitive function and worse physical health outcomes. This study aims to test whether polygenic risk for Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), or frontotemporal dementia (FTD) is associated with cognitive function and physical health in the UK Biobank, a cohort of healthy individuals. Group-based analyses were then performed to compare the top and bottom 10% for the three neurodegenerative polygenic risk scores; these groups were compared on the cognitive and physical health variables. Higher polygenic risk for AD, ALS, and FTD was associated with lower cognitive performance. Higher polygenic risk for FTD was also associated with increased forced expiratory volume in 1s and peak expiratory flow. A significant group difference was observed on the symbol digit substitution task between individuals with high polygenic risk for FTD and high polygenic risk for ALS. The results suggest some overlap between polygenic risk for neurodegenerative disorders, cognitive function and physical health.

Pubmed ID: 29856801

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: MR/K026992/1
  • Agency: Medical Research Council, United Kingdom
    Id: MC_U147585827
  • Agency: Medical Research Council, United Kingdom
    Id: MC_QA137853
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12011/2
  • Agency: Medical Research Council, United Kingdom
    Id: MC_U147585819
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UP_A620_1014
  • Agency: Medical Research Council, United Kingdom
    Id: MR/S015132/1
  • Agency: Medical Research Council, United Kingdom
    Id: G0400491
  • Agency: Medical Research Council, United Kingdom
    Id: MC_U147585824
  • Agency: Medical Research Council, United Kingdom
    Id: MR/L023784/2
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12011/1
  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_17228
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/F019394/1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


UK Biobank (tool)

RRID:SCR_012815

Biobank provides data collected at Assessment Center and via online questionnaires on participants aged 40-69 years recruited throughout United Kingdom and provides summary information to improve prevention, diagnosis and treatment of serious and life threatening illnesses.

View all literature mentions